Carolyn Haskins, MS, CGC

Carolyn obtained her Bachelor of Science (B.S.) in health education from the University of Florida and her Master of Science (M.S.) in genetic counseling from the University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences. During her graduate coursework, Carolyn completed a thesis project entitled “Accuracy of the BRCAPro Risk Assessment Model in Males Presenting to MD Anderson for BRCA Testing.” Additionally, during her graduate studies, Carolyn served as a summer intern at Moffitt within the genetics department.

After graduate school Carolyn worked as a clinical cancer genetic counselor at Baylor Scott & White in Dallas, Texas for several years. Carolyn joined the Genetic Risk Assessment Clinic at Moffitt Cancer Center in 2015. Carolyn serves as a clinical supervisor and guest lecturer for the University of South Florida genetic counseling training program.

Carolyn has published on topics such as male breast cancer and the use of multi-gene cancer panels. Carolyn has presented original research at the American College of Medical Genetics, National Society of Genetic Counselors annual educational meeting and San Antonio Breast Cancer Symposium. Carolyn has an interest in progressing the field of genetic counseling by advocating for the recognition of genetic counselors by Medicare. Carolyn has spent time on Capitol Hill advocating for a bill supporting both access and advancement of genetic counselors. 

Carolyn feels deeply connected to the Moffitt Cancer Center as she is a native of Sarasota, Florida and finds deep satisfaction in working everyday to contribute to the cure and prevention of cancer.

• Berry DK, Gillis N, Padron E, Moore C, Barton LV, Gewandter KR, Haskins CG, Knepper TC. Interpretation of ambiguous TP53 test results: Mosaicism, clonal hematopoiesis, and variants of uncertain significance. J Genet Couns. 2024 Aug.33(4):916-926. Pubmedid: 37715966.
• Dean M, Hintz EA, Baker J, Reblin M, Quinn GP, Haskins C, Vadaparampil ST. Shared Decision-Making Experiences of Couples with Inherited Cancer Risk Regarding Family Building. J Health Commun. 2023 May.28(5):292-301. Pubmedid: 37078713.
• Weatherill CB, Burke SA, Haskins CG, Berry DK, Homer JP, Demeure MJ, Darabi S. Six case reports of NTHL1-associated tumor syndrome further support it as a multi-tumor predisposition syndrome. Clin Genet. 2023 Feb.103(2):231-235. Pubmedid: 36196035.
• Dean M, Baker JT, Reblin M, Hintz EA, Vadaparampil ST, Haskins C, Quinn GP. Feasibility, acceptability, and outcomes of a pilot intervention facilitating communication about family building between patients with inherited cancer risk and their partners. PEC Innov. 2022 Dec.1:100055. Pubmedid: 37213754. Pmcid: PMC10194220.